Innoviva (INVA) Treasury Shares (2010 - 2024)
Innoviva (INVA) posted Treasury Shares of $393.8 million for Q1 2024, little changed on a QoQ basis from $393.8 million in Q4 2023, and little changed year-over-year from $393.8 million in Q2 2023.
Innoviva (INVA) Treasury Shares (2010 - 2024) Analysis & Trends
Innoviva's Treasury Shares history runs 9 years deep, the most recent figure standing at $393.8 million for Q1 2024.
- Quarterly Treasury Shares changed 0.0% year-over-year to $393.8 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $393.8 million (changed 0.0% YoY) and the FY2023 annual result came in at $393.8 million, changed 0.0% from the prior year.
- Treasury Shares was $393.8 million for Q1 2024 at Innoviva, roughly flat from $393.8 million in the prior quarter.
- Across five years, Treasury Shares topped out at $32.0 million in Q2 2021 and bottomed at $32.0 million in Q2 2021.
- A 4-year average of $32.0 million and a median of $32.0 million in 2021 frame the typical range for Treasury Shares.
- Peak annual rise in Treasury Shares reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
- Innoviva's Treasury Shares stood at $393.8 million in 2021, then changed by 0.0% to $393.8 million in 2022, then changed by 0.0% to $393.8 million in 2023, then changed by 0.0% to $393.8 million in 2024.
- Business Quant data shows INVA's Treasury Shares at $393.8 million in Q1 2024, $393.8 million in Q4 2023, and $393.8 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 32.01 Mn |
| Mar 31, 2024 | 393.83 Mn |
| Mar 31, 2024 | 393.83 Mn |
| Mar 31, 2024 | 32.01 Mn |
| Dec 31, 2023 | 32.01 Mn |
| Dec 31, 2023 | 393.83 Mn |
| Dec 31, 2023 | 393.83 Mn |
| Dec 31, 2023 | 32.01 Mn |
| Sep 30, 2023 | 393.83 Mn |
| Sep 30, 2023 | 32.01 Mn |
| Sep 30, 2023 | 32.01 Mn |
| Sep 30, 2023 | 393.83 Mn |
| Jun 30, 2023 | 32.01 Mn |
| Jun 30, 2023 | 393.83 Mn |
| Jun 30, 2023 | 393.83 Mn |
| Jun 30, 2023 | 32.01 Mn |
| Mar 31, 2023 | 393.83 Mn |
| Mar 31, 2023 | 32.01 Mn |
| Mar 31, 2023 | 32.01 Mn |
| Mar 31, 2023 | 393.83 Mn |